EdU (5-Ethynyl-2'-deoxyuridine)
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| A0540 | 5 mg | – | in stock | |
| 10540 | 100 mg | $120 | in stock | |
| 20540 | 250 mg | $195 | in stock | |
| 30540 | 500 mg | $345 | in stock | |
| 40540 | 1 g |
$590
|
in stock | |
| 60540 | 5 g | please inquire | in stock |
EdU (5-ethynyl-2’-deoxyuridine) is a nucleoside, an analog of thymidine, carrying an ethynyl group. This nucleoside behaves as a substrate for cellular DNA replication machinery. After EdU incorporation, DNA containing ethynyl groups can be ligated by click chemistry reaction with various dye azides. Fluorescent DNA can be detected with microscopy, or cells can be sorted with FACS.
Recommended protocol
Calculator
Customers also purchased with this product
sulfo-Cyanine3 hydrazide
Cyanine3 hydrazide with sulfo groups, well soluble in water and readily reacting with carbonyl compounds.sulfo-Cyanine5.5 maleimide
sulfo-Cyanine5.5 is a water-soluble far-red emitting dye. This is a thiol-reactive maleimide derivative of sulfo-Cyanine5.5. It is recommended for the labeling of sensitive proteins.Copper(II)-BTTAA complex
A catalyst for copper-catalyzed click reactions in aqueous media. A stable сopper(II) complex with BTTAA which must be converted to copper(I) using reducing agents. The complex can be used to prepare a reaction buffer of any composition.General properties
| Appearance: | light beige to light brown solid |
| Molecular weight: | 252.22 |
| CAS number: | 61135-33-9 |
| Molecular formula: | C11H12N2O5 |
| Solubility: | in water, DMSO |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. |
| MSDS: | Download |
| Product specifications |
Product citations
- Minutti, C.M.; Piot, C.; Pereira da Costa, M.; Chakravarty, P.; Rogers, N.; Huerga Encabo, H.; Cardoso, A.; Loong, J.; Bessou, G.; Mionnet, C.; Langhorne, J.; Bonnet, D.; Dalod, M.; Tomasello, E.; Reis e Sousa, C. Distinct ontogenetic lineages dictate cDC2 heterogeneity. Nature Immunology, 2024, 25, 448–461. doi: 10.1038/s41590-024-01745-9
- Dopeso, H.; Rodrigues, P.; Cartón-García, F.; Macaya, I.; Bilic, J.; Anguita, E.; Jing, L.; Brotons, B.; Vivancos, N.; Beà, L.; Sánchez-Martín, M.; Landolfi, S.; Hernandez-Losa, J.; Ramon y Cajal, S.; Nieto, R.; Vicario, M.; Farre, R.; Schwartz Jr, S.; van Ijzendoorn, S.C.D.; Kobayashi, K.; Martinez-Barriocanal, Á.; Arango, D. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis. iScience, 2024, 27(4), 109400. doi: 10.1016/j.isci.2024.109400
- Alruwaili, M.M.; Zonneville, J.; Naranjo, M.N.; Serio, H.; Melendy, T.; Straubinger, R.M.; Gillard, B.; Foster, B.A.; Rajan, P.; Attwood, K.; Chatley, S.; Iyer, R.; Fountzilas, C.; Bakin, A.V. A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers. Cell Reports Medicine, 2024, 5(3), 101434. doi: 10.1016/j.xcrm.2024.101434
- Swan, J.; Szabó, Z.; Peters, J.; Kummu, O.; Kemppi, A.; Rahtu-Korpela, L.; Konzack, A.; Hakkola, J.; Pasternack, A.; Ritvos, O.; Kerkelä, R.; Magga, J. Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease. Biomedicine & Pharmacotherapy, 2024, 175, 116683. doi: 10.1016/j.biopha.2024.116683
The count of items is incorrect.
Your cart is empty
$ 
